Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Long Term Debt of $100.82 million for the year ending 2024.
- LIFECORE BIOMEDICAL, INC. \DE\ showed an increase of +19.7% in Long Term Debt from 2023 to 2024.
- This data is from LIFECORE BIOMEDICAL, INC. \DE\'s annual report (Form 10-K), filed with the SEC on August 26, 2024.
- XBRL data for this metric is available from 2011 to 2024 (21 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $14.50 million | Q4 2011: $13.17 million | Q1 2012: $12.17 million | Q3 2012: $38.94 million | Q4 2012: $37.19 million | Q1 2013: $35.79 million | Q3 2013: $32.96 million | Q4 2013: $31.19 million | Q1 2014: $29.76 million | Q3 2014: $33.05 million | Q4 2014: $34.68 million | Q1 2015: $32.90 million | Q3 2015: $32.95 million | Q4 2015: $34.69 million | Q1 2016: $48.61 million | Q3 2016: $44.07 million | Q4 2016: $44.77 million | Q1 2017: $43.53 million | Q3 2017: $41.06 million | Q4 2017: $39.83 million | Q1 2018: $38.60 million | Q3 2018: $36.13 million | Q4 2018: $34.89 million | Q1 2019: $89.64 million | Q3 2019: $84.75 million | Q4 2019: $107.47 million | Q1 2020: $104.54 million | Q3 2022: $95.87 million | Q4 2022: $0.00 | Q3 2023: $88.06 million | Q4 2023: $92.09 million | Q1 2024: $96.34 million | Q2 2024: $100.82 million | Q3 2024: $105.55 million | Q4 2024: $110.53 million.
- Over the full 21 years of available data (2011 to 2024), LIFECORE BIOMEDICAL, INC. \DE\'s Long Term Debt has grown by 550.4%.
- Historical annual values: Fiscal year 2024: $100.82 million | Fiscal year 2023: $84.26 million | Fiscal year 2023: $98.90 million | Fiscal year 2022: $0.00 | Fiscal year 2022: $79.60 million | Fiscal year 2021: $124.19 million | Fiscal year 2021: $123.83 million | Fiscal year 2021: $164.90 million | Fiscal year 2021: $145.05 million | Fiscal year 2020: $82.00 million | Fiscal year 2020: $93.92 million | Fiscal year 2020: $101.36 million | Fiscal year 2019: $87.19 million | Fiscal year 2018: $37.36 million | Fiscal year 2017: $42.30 million | Fiscal year 2016: $45.97 million | Fiscal year 2015: $34.17 million | Fiscal year 2014: $28.32 million | Fiscal year 2013: $34.37 million | Fiscal year 2012: $40.31 million | Fiscal year 2011: $15.50 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: